BioLeaders Corporation

Quick facts

Phase 2 pipeline

• BLS-ILB-E710c
  BLS-ILB-E710c is an investigational drug with unknown mechanism of action.
• Poly-gamma Glutamic Acid

Phase 1 pipeline

• BLS-M22

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• BioLeaders Corporation portfolio CI brief
• BioLeaders Corporation pipeline updates RSS

Related

• Sector hub: All tracked pharma companies